More Dermatologists are Turning to Mohs for Melanoma in Situ
Dermatologists have come to view melanoma in situ (MIS) as quite the challenge. This is because the margins of this form of skin cancer are usually poorly defined. Because we are witnessing an increase in the diagnosis of MIS, it is becoming increasingly necessary for doctors to stay abreast of advances in treatment options. Currently, […]
- Posted on: Jul 15 2019
- Leave a response
